Literature DB >> 3965573

Evidence for the role of class I and class II HLA antigens in the lytic function of a cloned line of human natural killer cells.

J Kornbluth, B Spear, S S Raab, D B Wilson.   

Abstract

Monoclonal antibodies with specificity for HLA class I and class II antigens were generated which either inhibit or enhance the lytic activity of a cloned line of human NK cells. These antibodies were obtained from a fusion with spleen cells from mice immunized with NK clone 3.3. They affect the lytic function of that clone at the level of the killer cell; additional evidence suggests that the effect takes place during an early stage of lysis. Immunoprecipitation and cross-clearing experiments using MHC antibodies of known specificity demonstrate the reactivity of mAbs 131 and 164 with HLA class I antigens and mAbs 210 and 273 with HLA class II antigens. Binding studies indicate that these antibodies are probably recognizing nonpolymorphic MHC determinants. Although these antibodies bind to other NK effector cells tested, they have no effect on the lytic function of these bulk NK populations. Preliminary studies, however, indicate that they do affect the NK activity of a proportion of the clones within these bulk populations. To further assess the potential role of HLA gene products in the lytic function of NK3.3, several well-defined anti-MHC antibodies were tested for their effects on NK3.3 function. The anti-HLA class I and class II antibodies could each be grouped into functional categories based on their ability to enhance, inhibit, or not affect the lysis of NK-sensitive targets K562 and MOLT-4 by NK clone 3.3. These results demonstrate, for the first time, a potential involvement of MHC molecules with NK function.

Entities:  

Mesh:

Substances:

Year:  1985        PMID: 3965573

Source DB:  PubMed          Journal:  J Immunol        ISSN: 0022-1767            Impact factor:   5.422


  8 in total

1.  Purification and characterization of cytolytic and noncytolytic human natural killer cell subsets.

Authors:  L T Lebow; B Bonavida
Journal:  Proc Natl Acad Sci U S A       Date:  1990-08       Impact factor: 11.205

2.  Functional role of HLA class I cell-surface molecules in human T-lymphocyte activation and proliferation.

Authors:  D S Taylor; P C Nowell; J Kornbluth
Journal:  Proc Natl Acad Sci U S A       Date:  1986-06       Impact factor: 11.205

3.  Use of anti-HLA antibodies to mask major histocompatibility complex gene products on tumor cells can enhance susceptibility of these cells to lysis by natural killer cells.

Authors:  P I Lobo; C E Spencer
Journal:  J Clin Invest       Date:  1989-01       Impact factor: 14.808

4.  Natural killer-cell activity in cyclosporine-treated renal allograft recipients.

Authors:  M Lefkowitz; J Kornbluth; J E Tomaszewski; D K Jorkasky
Journal:  J Clin Immunol       Date:  1988-03       Impact factor: 8.317

5.  Pulmonary alveolar macrophages in patients with sarcoidosis and hypersensitivity pneumonitis: characterization by monoclonal antibodies.

Authors:  C Agostini; L Trentin; R Zambello; M Luca; M Masciarelli; A Cipriani; G Marcer; G Semenzato
Journal:  J Clin Immunol       Date:  1987-01       Impact factor: 8.317

6.  Evidence for a shared HLA-A intralocus determinant defined by monoclonal antibody 131.

Authors:  B T Spear; J Kornbluth; J L Strominger; D B Wilson
Journal:  J Exp Med       Date:  1985-12-01       Impact factor: 14.307

Review 7.  Advantages and applications of CAR-expressing natural killer cells.

Authors:  Wolfgang Glienke; Ruth Esser; Christoph Priesner; Julia D Suerth; Axel Schambach; Winfried S Wels; Manuel Grez; Stephan Kloess; Lubomir Arseniev; Ulrike Koehl
Journal:  Front Pharmacol       Date:  2015-02-12       Impact factor: 5.810

Review 8.  Reverse Signaling by MHC-I Molecules in Immune and Non-Immune Cell Types.

Authors:  Elke M Muntjewerff; Luca D Meesters; Geert van den Bogaart; Natalia H Revelo
Journal:  Front Immunol       Date:  2020-12-15       Impact factor: 7.561

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.